INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Company

Cartesian Therapeutics, Inc.

Filed

November 17, 2023

Period of Report

November 13, 2023

Accession Number

0001062993-23-021043